Zus Health is a technology company.
Zus Health has raised $74.0M across 2 funding rounds.
Zus Health has raised $74.0M in total across 2 funding rounds.
Zus Health is a Boston-based health tech company founded in 2020 that builds a shared health data platform to accelerate healthcare data interoperability.[1][4] Its core product, the Zus Aggregated Profile (ZAP), aggregates and unifies patient data—including demographics, conditions, medications, diagnostics, encounters, notes, documents, allergies, immunizations, and care team details—delivering a comprehensive, de-duplicated view accessible at the point of care via APIs, embedded components, and direct EHR integrations.[1][3][7] Zus serves healthcare organizations, clinicians, health tech developers, and information exchanges, solving the problem of fragmented, siloed data that hinders patient outcomes, care team efficiency, and innovation by providing easy-to-use, intelligently refreshed patient insights.[2][3][5] The company demonstrates strong growth momentum, with recent announcements of new clients, AI-powered innovations like human-readable narrative summaries and risk-suspecting engines, and seamless integrations reported by early adopters as of February 2025.[1]
Zus Health, formerly known as Zeus Healthcare Technologies, was founded in 2020 in Boston, Massachusetts, amid growing frustrations with healthcare's data silos.[1] Key leadership includes CEO Jonathan Bush, a serial entrepreneur with prior experience at athenahealth, who has emphasized rewiring healthcare for speed and clinical truth.[1] The idea emerged from the need to unify disconnected patient data into actionable records, enabling builders to innovate without rebuilding infrastructure—catalyzing "healthcare’s greatest inventors" by maximizing patient insights.[2][6] Early traction built around the Zus Grid and ZAP, with pivotal expansions into AI-driven tools and partnerships like Elation Health, positioning Zus as a foundational platform for value-based care.[1][3]
Zus stands out in health tech through these key strengths:
Zus rides the wave of healthcare data interoperability and AI-driven value-based care, addressing chronic fragmentation across EHRs and systems that stalls innovation and outcomes.[1][4][5] Timing is ideal amid regulatory pushes like TEFCA and rising demand for real-time insights in a post-pandemic era prioritizing efficiency and prevention.[1] Market forces favoring Zus include explosive growth in health tech builders needing scalable data platforms, plus AI's ability to surface risks and gaps beyond traditional settings.[1][2] By enabling seamless data sharing, Zus influences the ecosystem as infrastructure for developers, clinicians, and exchanges—unlocking business value, reducing hospitalizations, and fostering a "clinical truth" standard that accelerates broader transformation.[1][3][5]
Zus Health is poised for rapid scaling with its AI suite in testing and client wins signaling product-market fit in a $100B+ interoperability market.[1] Upcoming trends like advanced care gap identification and expanded AI will shape its path, potentially dominating as health systems shift to proactive, data-unified models.[1] Its influence could evolve from enabler to category leader, rewiring care delivery as Bush envisions—starting with aggregated profiles that humanize data for inventors building the future.[1][2] This positions Zus as essential infrastructure in an increasingly connected health ecosystem.
Zus Health has raised $74.0M in total across 2 funding rounds.
Zus Health's investors include Andreessen Horowitz, Jazz Venture Partners, Primary Venture Partners, Richard Branson.
Zus Health has raised $74.0M across 2 funding rounds. Most recently, it raised $40.0M Series A in March 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Mar 1, 2023 | $40.0M Series A | Andreessen Horowitz, Jazz Venture Partners, Primary Venture Partners, Richard Branson | |
| Jun 1, 2021 | $34.0M Series A | Andreessen Horowitz, Primary Venture Partners, Richard Branson |